China SXT Pharmaceuticals, Inc. announced that it has entered into a securities purchase agreement with returning investor, Streeterville Capital, LLC that it will issue an unsecured promissory note in the original principal amount of $797,500 , convertible into ordinary shares, $0.08 par value per share, of the Company for the gross proceeds of $750,000 on May 9, 2024. The May 2024 Note bears interest at a rate of 6% per annum compounding daily. All outstanding principal and accrued interest on May 2024 Note will become due and payable twelve months after the purchase price of May 2024 Note is delivered by Purchaser to the Company.